Skip to content

    Medi Assist Ser.

    MEDIASSIST
    Financial Services·11 May 2026
    Management Summary

    Medi Assist Healthcare Services reported a strong Q4 and FY26, marked by robust operating income growth of 25.1% and an expanded operating EBITDA margin of 19.9% in Q4. The company achieved debt-free status and saw its technology SaaS platform revenue grow by 91.9% YoY. Integration of Paramount TPA is progressing well, with AI-powered solutions demonstrating significant fraud prevention capabilities, though retail market share and group retention saw slight dips.

    Highlights

    6
    • Operating income grew 25.1% YoY to INR904.8 crores, driven by strong performance across segments.

    • Operating EBITDA margin expanded to 19.9% in Q4 FY26, showing quarterly improvement from 17.1% in Q2 and 18.6% in Q3.

    • The company achieved debt-free status in January 2026, strengthening its ability to invest in the future.

    • Technology SaaS platform revenue saw a significant surge of 91.9% YoY, reaching INR21.7 crores, indicating successful tech-led transformation.

    • AI-powered MAven Guard prevented over INR540 crores of health insurance frauds, demonstrating the effectiveness of technology investments.

    • Paramount TPA integration is on track, with over 50% of claims migrated to MAtrix and expected to be the primary processing engine by Q2 FY27.

    Concerns

    3
    • Retail segment market share in the traditional TPA model was 5% on March 31, 2026, slightly lower than the previous year.

    • Group premiums retention stood at 93.2% (excluding acquisition), marginally lower than the historical 94%+ due to deliberate decisions on revenue quality and operational changes.

    • Revenue translation from core business growth is slightly slower due to reporting on a 12-month basis and a significant portion sitting in contract liability (INR280.2 crores).

    Key financials

    Metrics

    11

    Periods

    2

    Headline

    10
    • Total Premium Under Management
      ₹25,923 Cr
      YoY+22.8%
    • Total Income
      ₹923.2 Cr
      YoY+23.6%
    • Operating Income
      ₹904.8 Cr
      YoY+25.1%
    • Operating EBITDA
      ₹174.6 Cr
      YoY+13.3%
    • Operating EBITDA Margin
      19.3%

    Q4

    1
    • EBITDA Margin
      19.9%

    Segment breakdown

    • Group₹629.1 Cr69.8%
    • Retail₹95.5 Cr10.6%
    • Government₹113.6 Cr12.6%
    • International Benefits Administration₹41.1 Cr4.6%
    • Technology SaaS platform₹21.7 Cr2.4%
    Donut· Share of Revenue

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Debt disclosed

    M&A

    Paramount TPA

    acquisition · integrated

    Liquidity

    Cash ₹260.5 crores

    The free cash flow position as on date was INR260.5 crores.

    Guidance & targets

    5
    CategoryTargetPriority
    Integration
    Paramount TPA integration completion
    Primary processing engine before Q2 FY27
    High
    Integration
    Paramount TPA integration timeline
    1-2 more quarters
    High
    Profitability
    Technology business margin profile
    1.5-2x traditional TPA business
    Medium
    Growth
    Core business growth
    match or better industry growth
    Medium
    Market Share
    Health insurance market share
    20.7%
    High

    Paramount TPA integration completion

    Next 1-2 quarters
    Current3 quarters down, 50%+ claims migrated
    TargetPrimary processing engine by Q2 FY27

    Why it matters

    Key to realizing synergies and expanding the TPA business, impacting overall operational efficiency and profitability.

    I think we still track to being 1 or 2 quarters at the most from a Paramount perspective.

    How to verify

    capital_allocation.m_and_a[target='Paramount TPA'].status

    Risks & concerns

    3
    RiskSeverity

    Group premium retention marginally lower than historical

    Group premiums retention stood at 93.2%, marginally lower than historical 94%+ due to deliberate decisions on quality of revenue and operational changes, with expectations for improvement.Management acknowledged

    medium

    Slower revenue translation from core business growth

    Revenue translation is slower because the company reports on a 12-month basis, and a significant portion of revenue sits in contract liability (INR280.2 crores) before being booked to P&L.Management acknowledged

    low

    IT-ITES slowdown impacting group segment international business

    A slowdown in the IT-ITES sector has led to reduced headcounts in India, impacting the group segment of international business, though other industries are picking up.Management acknowledged

    low

    Q&A highlights

    7

    “Retail for a very long time was plain as if I have to put it plain vanilla catastrophic care, inpatient only, with a very low incidence, very low frequency, low frequency and high value claims... So, retail has in our mind is evolved to be for lack of better words a hybrid you know approach across the country.”

    Explains the historical challenges and evolving strategy for retail market penetration, contrasting it with group business.

    asked by Navid Virani

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Financial Performance and Debt-Free Status

    Medi Assist reported a robust Q4 and FY26, with total income growing 23.6% YoY to INR923.2 crores and operating income increasing 25.1% YoY to INR904.8 crores. The company achieved debt-free status in January 2026, enhancing its financial flexibility. Operating EBITDA for FY26 stood at INR174.6 crores, a 13.3% YoY growth, with the Q4 EBITDA margin expanding to 19.9% from 18.6% in Q3 and 17.1% in Q2, indicating improving operational efficiency.

    02

    Technology-Led Transformation and AI Impact

    FY26 was a milestone year for technology-led transformation, with tech revenues surging 91.9% YoY to INR21.7 crores. The company's AI-powered platform, MAven Guard, successfully prevented over INR540 crores in health insurance frauds and delivered INR1,300 crores in network discounts. Management highlighted that the technology business aims for a margin profile 1.5 to 2 times higher than traditional TPA services, focusing on capturing non-headcount portions of revenue.

    03

    Paramount TPA Integration Progress

    The integration of Paramount TPA is well underway, with over 50% of its claims volume already migrated to Medi Assist's MAtrix platform. The company expects Paramount to become the primary processing engine before Q2 FY27, with the full integration process anticipated to be completed within the next 1-2 quarters. A slump transfer of Paramount TPA's operations to Medi Assist TPA was executed on February 1, 2026, creating a unified TPA business.

    04

    Segmental Growth and Market Share

    The Group segment contributed 69.5% of total revenue, growing 25.3% YoY to INR629.1 crores, with a market share of 33.7%. Retail revenue grew 10.9% YoY to INR95.5 crores, though its traditional TPA model market share was slightly lower at 5%. Government business showed strong growth of 42.6% YoY, reaching INR113.6 crores. Overall, the company's market share in health insurance premium administered in group and retail reached 20.7% by year-end, a 115 basis points YoY growth.

    05

    Strategic Focus on International Expansion

    Medi Assist is expanding its global footprint, deepening its Southeast Asia presence through a strategic partnership in Thailand, gaining access to over US$50 million in group premiums. The company is also building key global partnerships with entities like Freedom Health and Himalayan Everest Insurance. The strategy for international markets is to deploy its technology and capabilities in regions like Southeast Asia, which have similar workflows and quicker deployment cycles.

    06

    Government Initiatives and Industry Outlook

    Management discussed the government's vision of 'insurance for all by 2047' and initiatives like Bima Sugam and Ayushman Bharat Digital Mission. Medi Assist views these as opportunities, not disruptions, and is actively partnering with the National Health Claims Exchange (NHCX). The company believes its core business will match or exceed overall industry growth, despite some slowdowns in the IT-ITES sector impacting international group business.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.